TONIX PHARM HLDG COR | TalkMarkets

Latest Posts

Coronavirus Update - Some Stock Picks For The Pandemic

Article By: Paradigm Press

Thursday, March 26, 2020 12:43 PM EDT

There are so many coronavirus related plays right now. As the market is crashing (despite rebounding today), coronavirus stocks are hot. Here are a few examples from last Friday’s market close…

In this article: TNXP, MEDS, NBDR, GNMK, BLPH, GAXY, XSPA

Read

Tonix Pharmaceuticals Prices $9.0 Million Public Offering

Article By: NASDAQ GlobeNewswire

Friday, November 15, 2019 9:36 AM EDT

Tonix Pharmaceuticals Holding Corp., announced today the pricing of an underwritten public offering with expected total gross proceeds of $9.0 million before deducting underwriting discounts, commissions and other offering expenses.

In this article: TNXP

Read

Tonix Pharmaceuticals Completes $8 Million Public Offering Of Common Stock

Article By: NASDAQ GlobeNewswire

Tuesday, April 4, 2017 7:06 PM EDT

Tonix Pharmaceuticals Holding Corp. announced the closing of its previously announced underwritten public offering of 1,800,000 shares of its common stock at an offering price of $4.45 per share of common stock.

In this article: TNXP

Read

Tonix Pharmaceuticals Shares Plummet 50% On Phase 3 Trial Failure

Article By: Terry Chrisomalis

Tuesday, September 6, 2016 9:09 AM EDT

On Tuesday, Tonix Pharmaceuticals announced that it had failed its phase 3 trial in patients with Fibromyalgia. The phase 3 trial, known as the "AFFIRM" trial, failed to meet on the primary endpoint of the study.

In this article: TNXP

Read